Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Clinical testing for neutralizing antibodies to interferon-β in multiple sclerosis.
[2012: news in neurology].
[Compensatory mechanisms in multiple sclerosis(review)].
Disease-specific molecular events in cortical multiple sclerosis lesions.
Development of protein biomarkers in cerebrospinal fluid for secondary progressive multiple sclerosis using selected reaction monitoring mass spectrometry (SRM-MS).
Cognitive reserve in multiple sclerosis: Protective effects of education.
Role of vitamin D in regulating the neural stem cells of mouse model with multiple sclerosis.
Autologous hematopoietic stem cell transplantation for multiple sclerosis - if confused or hesitant, remember: 'Treat with standard immune suppressive drugs and if no inflammation, no response'.
Immunomodulatory synergy by combining atorvastatin and rapamycin in the treatment of experimental autoimmune encephalomyelitis (EAE).
A new therapeutic target for the treatment of multiple sclerosis.
Depression in multiple sclerosis: a review of assessment and treatment approaches in adult and pediatric populations.
Progesterone alleviates neural behavioral deficits and demyelination with reduced degeneration of oligodendroglial cells in cuprizone-induced mice.
Facilitation of Corticospinal Connections in Able-bodied People and People With Central Nervous System Disorders Using Eight Interventions.
Downbeat nystagmus associated with damage to the medial longitudinal fasciculus of the pons: A vestibular balance control mechanism via the lower brainstem paramedian tract neurons.
Preventing brain atrophy should be the gold standard of effective therapy in multiple sclerosis (after the first year of treatment): Commentary.
Vowel Acoustics in Parkinson's disease and Multiple Sclerosis: Comparison of Clear, Loud and Slow Speaking Conditions.
Pathology of multiple sclerosis: where do we stand?
An RCT to treat learning impairment in multiple sclerosis: The MEMREHAB trial.
Prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: a blinded sonographic evaluation.
ISENTRESS® prescribing information
Corpus Callosum Atrophy Correlates with Gray Matter Atrophy in Patients with Multiple Sclerosis.
Protective Effect of a cAMP Analogue on Behavioral Deficits and Neuropathological Changes in Cuprizone Model of Demyelination.
Autoimmune disease prevalence in a multiple sclerosis cohort in Argentina.
Walking capacity and ability are more impaired in progressive compared to relapsing type of multiple sclerosis.
Spinal cord imaging in multiple sclerosis: Filling the gap with the brain.

Pages